4yo snakebite victim given anti-rabies shot at Sambhal hosp; pharmacist removed from duty

Meerut: A four-year-old boy’s condition allegedly worsened after he was administered an anti-rabies injection at Sambhal district hospital following a snakebite. A pharmacist at the hospital has been removed from his duties pending an inquiry, officials said on Friday.

The boy, identified by his first name, Adeeb, a resident of Sambhal, was bitten by a snake on Monday while playing in the courtyard of his house. He had put his hand into a hole in a wall to retrieve a marble when the snake struck him, his family said.

The boy was taken to the district hospital, where staff allegedly insisted he had been stung by a wasp despite their repeated claims that he had suffered a snakebite. “We kept telling them that he had been bitten by a snake, but they did not listen,” Adeeb’s father, Abul Hasan, said.

The boy was administered an anti-rabies injection instead of an anti-venom and sent home with medicines, the family alleged. Later that evening, he began vomiting and his body turned cold. “We immediately took him to a private hospital, where doctors confirmed that he had suffered a snakebite,” he said.

Sambhal district hospital chief medical superintendent Rajendra Singh told TOI that Adeeb was brought to the hospital when the doctor on duty was unavailable and that a pharmacist, who is also a govt employee, had prescribed the anti-rabies injection.

“The pharmacist has been removed from all duties, while a three-member committee has written to the director general, seeking action against him. The district magistrate is also conducting an inquiry into the incident,” Singh said.

Adeeb is undergoing treatment at a private hospital and his condition is said to be stable. His family has demanded strict action against those responsible for the alleged lapse.

  • Related Posts

    Not mandatory to recall stocks released to the market prior to implementation of TMR: NPPA

    The National Pharmaceutical Pricing Authority (NPPA) has said that it is not mandatory for the oncology drug manufacturers who are revising the drug prices as per the recently announced Trade…

    Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 crore

    Mankind Pharma shares jumped nearly 8% on Tuesday to an intraday high of Rs 2,500 on the NSE after the company reported a 38% year-on-year rise in Q2 profit after…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Not mandatory to recall stocks released to the market prior to implementation of TMR: NPPA

    Not mandatory to recall stocks released to the market prior to implementation of TMR: NPPA

    Yashoda Medicity: Baby takes a Giant Step in just One Year

    Yashoda Medicity: Baby takes a Giant Step in just One Year

    Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 crore

    Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 crore

    GLP-1 injections recalled across the US over sterility concerns

    GLP-1 injections recalled across the US over sterility concerns

    Govt allows third-party agencies to conduct departmental inspections

    Govt allows third-party agencies to conduct departmental inspections

    Fridge-free vaccines could reach more people, but there are still practical challenges in African settings

    Fridge-free vaccines could reach more people, but there are still practical challenges in African settings